Exelixis (EXEL) Amortizatization of Intangibles (2010 - 2019)
Exelixis (EXEL) posted quarterly Amortizatization of Intangibles of $704000.0 for Q3 2019, down 74.23% year-over-year from $2.7 million in Q3 2018, and up 6.83% quarter-over-quarter from $659000.0 in Q2 2019.
Analysis
Exelixis (EXEL) Amortizatization of Intangibles (2010 - 2019) Analysis & Trends
Exelixis' Amortizatization of Intangibles history runs 9 years deep, the most recent figure standing at $704000.0 for Q3 2019.
- In Q3 2019, Amortizatization of Intangibles fell 74.23% year-over-year to $704000.0; the TTM figure through Sep 2019 stood at -$6.2 million (down 177.9% YoY), while the FY2018 annual figure was $2.9 million, changed N/A from the prior year.
- Amortizatization of Intangibles for Q3 2019 stood at $704000.0, up from $659000.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $7.7 million in Q1 2015, with the low at -$7.7 million in Q1 2019.
- The 4-year median for Amortizatization of Intangibles is $3.8 million (2015), against an average of $2.7 million.
- The sharpest annual moves came in 2015 and 2019: Amortizatization of Intangibles advanced 9.83% in 2015, then slumped 74.23% in 2019.
- Exelixis' Amortizatization of Intangibles stood at $4.8 million in 2015, then gained by 9.19% to $5.3 million in 2016, then slumped by 97.69% to $122000.0 in 2018, then jumped by 477.05% to $704000.0 in 2019.
- Business Quant data shows EXEL's Amortizatization of Intangibles at $704000.0 in Q3 2019, $659000.0 in Q2 2019, and -$7.7 million in Q1 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 4.33 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 678,000.00 |
| 10 | Exelixis | 14.81 Bn | 13.97 Bn | 608.03 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 27, 2019 | 704,000.00 |
| Jun 28, 2019 | 659,000.00 |
| Mar 29, 2019 | -7.73 Mn |
| Dec 28, 2018 | 122,000.00 |
| Sep 28, 2018 | 2.73 Mn |
| Mar 31, 2016 | 5.29 Mn |
| Dec 31, 2015 | 4.84 Mn |
| Sep 30, 2015 | 5.30 Mn |
| Jun 30, 2015 | 7.22 Mn |
| Mar 31, 2015 | 7.68 Mn |
| Dec 31, 2014 | 7.71 Mn |
| Sep 30, 2014 | 7.51 Mn |
| Jun 30, 2014 | 7.33 Mn |
| Mar 31, 2014 | 6.99 Mn |
| Dec 31, 2013 | 6.85 Mn |
| Sep 30, 2013 | 6.65 Mn |
| Jun 30, 2013 | 6.48 Mn |
| Mar 31, 2013 | 6.31 Mn |
| Dec 31, 2012 | 6.13 Mn |
| Sep 30, 2012 | 4.15 Mn |